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Abstract
Background: Schistosomiasis and soil-transmitted helminthiasis (STH) are among the neglected tropical diseases
in Africa. A national control program for these diseases was initiated in Uganda during March 2003. Annual
treatment with praziquantel and albendazole was given to schoolchildren in endemic areas and to adults in
selected communities where local prevalence of Schistosoma mansoni in schoolchildren was high.
Methods: The impact of the treatment program was monitored through cohorts of schoolchildren and adults.
Their infection status with S. mansoni and STH was determined by parasitological examinations at baseline and at
annual follow-ups. The prevalence and intensity of S. mansoni and STH before and after treatment were analyzed.
Results: Two rounds of treatment significantly reduced the prevalence of S. mansoni infection in schoolchildren
across three regions in the country from 33.4–49.3% to 9.7–29.6%, and intensity of infection from 105.7–386.8
eggs per gram of faeces (epg) to 11.6–84.1 epg. The prevalence of hookworm infection was reduced from 41.2–
57.9% to 5.5–16.1%, and intensity of infection from 186.9–416.8 epg to 3.7–36.9 epg. The proportion of children
with heavy S. mansoni infection was significantly reduced from 15% (95% CI 13.4–16.8%) to 2.3% (95% CI 1.6–
3.0%). In adults, significant reduction in the prevalence and intensity of S. mansoni and hookworm infections was
also observed. More importantly, the prevalence and intensity of both S. mansoni and hookworm infections in the
cohorts of newly-recruited 6-year-olds who had never previously received treatment decreased significantly over
2 years: 34.9% (95% CI 31.9–37.8%) to 22.6% (95% CI 19.9–25.2%) and 171.1 epg (95% CI 141.5–200.7) to 72.0
epg (95% CI 50.9–93.1) for S. mansoni; and 48.4% (95% CI 45.4–51.5) to 15.9% (95% CI 13.6–18.2) and 232.7 epg
(95% CI 188.4–276.9) to 51.4 epg (95% CI 33.4–69.5) for hookworms, suggesting a general decline in
environmental transmission levels.
Conclusion: Annual anthelminthic treatment delivered to schoolchildren and to adults at high risk in Uganda can
significantly reduce the prevalence and intensity of infection for schistosomiasis and STH, and potentially also
significantly reduce levels of environmental transmission of infection.
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Schistosomiasis is a parasitic disease caused by infection
with blood-fluke trematode schistosomes through contact
with infective larvae in aquatic habitats of poor hygiene
and sanitation that contain freshwater snails, the para-
sites' intermediate host. In Africa, two forms of human
schistosomiasis occur: intestinal schistosomiasis due to
Schistosoma mansoni and urinary schistosomiasis due to
Schistosoma haematobium. By contrast, soil-transmitted
helminthiasis (STH) is caused by infection with a group of
intestinal nematode worms, most importantly in much of
sub-Saharan Africa, the hookworms, Ascaris lumbricoides
and Trichuris trichiura, through contact with parasite eggs
or larvae that are present in the contaminated environ-
ment. Both schistosomiasis and STH are among the
neglected tropical diseases that remain serious public
health problems, posing unacceptable threats to human
health and welfare, especially in the developing world. In
total around 200 million people worldwide are estimated
to be infected with schistosomes [1-3], and the numbers
of STH infections are much greater [4-7]. The combined
loss of 'disability-adjusted life years' due to the above par-
asitic infections is 43.5 million [6-8], only ranking behind
those for lower respiratory infections (91.3 million), HIV/
AIDS (84.5 million), diarrhoeal diseases (62 million),
and malaria (46.5 million) [9,10]. Moreover, the disabil-
ity-adjusted life years for schistosomiasis recently have
been considered to greatly underestimate the true burden
of the disease and are in need of reassessment [11-15].
Therefore, the actual total burden of these parasitic infec-
tions could be much greater. It is well documented that
these infections have a debilitating effect on people's
health, especially children – the most vulnerable group.
Schistosomiasis alone could be responsible for 200000
deaths per year in sub-Saharan Africa, and STH could be
responsible for 135000 deaths per year globally [14].
Despite these facts, the control of these neglected tropical
diseases has not previously been given priority within the
national health programs of many of the sub-Saharan
African countries. The main reasons for this are, first, that
many of these parasitic infections can be asymptomatic
and less overtly life-threatening than diseases such as HIV/
AIDS, tuberculosis, and malaria and, second, that the nec-
essary anthelminthic drugs have been too expensive for
widespread use within countries with limited financial
resources.
In Uganda, intestinal schistosomiasis has long been
known to be prevalent, being dominant in 38 out of 58
districts within regions surrounding Lakes Victoria and
Albert and the Albertine Nile area [16-18]. While urinary
schistosomiasis also occurs in Uganda, its distribution is
confined to a few isolated foci within central Uganda [18].
Recent surveys conducted between 1998 and 2002
showed that 16.7 million people, out of a total popula-
tion of 24 million people in 108 counties, were estimated
to be at risk of infection with S. mansoni [18]. The level of
infection in the human population was closely related to
the proximity with local water bodies where daily water
contact activities such as washing and bathing occur.
Places with the highest prevalence were closer to the
immediate shorelines of Lakes Victoria and Albert, and in
certain locations infections were nearly universal (100%)
[18]. Hookworm infections tend to be widespread
throughout the country with a prevalence of up to 90%,
while A. lumbricoides and T. trichiura infections tend to be
more geographically restricted, being greatest in the
southwestern districts and to a lesser extent in central and
part of eastern Uganda (up to 89% and 68%, respectively)
[19-22]. Although some individual treatment projects had
been carried out in certain areas of the country, the imple-
mentation of the first systemic national control program
for schistosomiasis and STH was not initiated until 2003,
despite the fact that a very effective drug, praziquantel
(PZQ), has been available for decades. The current pro-
gram was made possible by the recent reduction in the
price of drugs [23] and the financial and technical support
from the Schistosomiasis Control Initiative, funded by the
Bill and Melinda Gates Foundation.
By the beginning of 2005, two rounds of annual mass
chemotherapy with PZQ and albendazole (ALB) had been
delivered. Approximately 3.5 million schoolchildren and
community adults at high risk had received treatment.
Cohorts of schoolchildren and community adults were
selected and followed-up annually to monitor the effect of
the control program. Previous analysis showed that the
treatment had significantly improved anaemia status,
which was associated with schistosomiasis and hook-
worm infections, and clinical manifestations in school-
children [24,25]. The aim of the current paper is to assess
in detail the significant impact of two rounds of mass
chemotherapy in this control program upon the preva-
lence and intensities of these parasitic infections in differ-
ent epidemiological settings, both on those treated
individuals and more importantly, also on the new
cohorts of 6-year-old untreated children, potentially
reflective of the subsequent transmission risk in the envi-
ronment.
Methods
National control program
The Ugandan national control program for schistosomia-
sis and STH was the first among the six in Africa supported
by the Schistosomiasis Control Initiative. The control
strategies used were school-based mass chemotherapy in
children and selective chemotherapy in adults at high risk
of schistosome infection, together with health education,
following the World Health Organization guidelines [7].
The program started initially in 18 districts, which werePage 2 of 11
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tions (Figure 1). The treatment strategy for each commu-
nity was decided according to its endemic category using
available epidemiological mapping data [18] and was
based on the schistosomiasis prevalence in the areas: (1)
where schistosomiasis prevalence was over 50% (high cat-
egory), annual mass treatment was given to schoolchil-
dren and community adults; (2) where schistosomiasis
prevalence was 10–50% (medium category), annual mass
treatment was given to schoolchildren only; and (3)
where schistosomiasis prevalence was below 10% (low
category), schoolchildren were treated in the first two
rounds of treatment only [7,23]. The details of the control
strategies and implementation of the program are
described elsewhere [26]. The dosage of PZQ was 40 mg/
kg body weight, co-administered with a single 400 mg
ALB tablet. PZQ tablets were procured from Shin Poong
(Seoul, Korea) and ALB from GlaxoSmithKline (Brent-
ford, Middlesex, UK). The treatment received ethical clear-
ance from the National Health System Local Research
Ethics Committee of St Mary's Hospital, London as well as
approval from the Ministry of Health and the National
Council of Science and Technology, Kampala, Uganda.
Monitoring cohorts and parasitological diagnosis
In order to monitor the impact of the treatment, identifi-
able cohorts of schoolchildren and community adults
were recruited and examined at baseline and at follow-ups
(Figure 2). The details of cohort selection and sample sizes
were described previously [24,27]. In brief, 37 primary
schools in eight districts were selected for monitoring
studies, representing three different transmission regions,
the Albertine Nile region (Nebbi, Moyo, and Arua dis-
tricts), the Lake Albert region (Hoima and Masindi dis-
tricts), and the Lake Victoria region (Busia, Bugiri, and
Mayuge districts), and three endemic categories as
described above. Within each district, five schools were
selected according to endemic categories: two from the
high category, two from the medium category, and one
from the low category, except that only one school was
surveyed in Arua, and six in Moyo due to logistical rea-
sons. Within each school, 120 children were selected ran-
domly on the basis of age (6-, 7-, 8-, or 11-year-olds) to
include approximately 15 boys and 15 girls in each age
group. We also selected nine communities from eight dis-
tricts where the initial prevalence in the school was high
(>50%). Approximately 120 people over the age of 14
were recruited from each community on a voluntary basis.
Diagram of the study structureFigure 2
Diagram of the study structure.
Ugandan treatment program
18 districts covered initially by the program
3 transmission regions:
Albertine Nile: 3 districts
Lake Albert:  2 districts
Lake Victoria: 3 districts
3 endemic categories:
High category: S. mansoni prevalence >50% 
Medium category: S. mansoni prevalence 10-50%
Low category: S. mansoni prevalence <10%
High category: 2 schools + 1 community
Medium category: 2 schools
Low category: 1 school
Total 4351 children aged 6, 7, 8 or 11 in 37 schools recruited 
Total 1006 adults aged over 14 in 9 communities recruited
Baseline data collected
1st mass treatment carried out 
1st follow-up carried out 12 months later
Same cohort children + new 6 year old recruits
Same cohort adults + new recruits due to drop-outs
8 districts selected for monitoring studies
2nd mass treatment carried out
2nd follow-up carried out 24 months later
Same cohort children + new 6 year old recruits
Same cohort adults + new recruits due to drop-outs
Interim data analysis
Map of the initial program coverage areas and the cohort scho l location in UgandaFigure 1
Map of the initial program coverage areas and the 
cohort school location in Uganda. The treatment pro-
gram initially covered the 18 districts shown in green, and 37 
schools shown as circles were selected from eight districts 
for follow-up monitoring.
 
 
 
      
 
 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
  
  
 
     
	
			


	



  
  
  
 

	


 	

		
	
		
 	
 

	

	 		
	


		
 
 	Page 3 of 11
(page number not for citation purposes)
BMC Medicine 2007, 5:27 http://www.biomedcentral.com/1741-7015/5/27A total of 4351 children and 1006 adults were recruited
and examined at baseline. The same cohorts of children
and adults, if traced, were re-examined 12 and 24 months
later, each in the same month of the year as when the
baseline survey was performed and before the next round
of treatment taking place. At each follow-up an additional
15 boys and 15 girls of 6 years of age were recruited from
each school. Due to the high dropout rate in the adult
cohorts, additional voluntary adults were examined in
each community at each follow-up. On each occasion,
faecal samples from all individuals were examined using
the single modified Kato-Katz thick smear [28] for schis-
tosomiasis and STH. The focal egg counts for each of the
four parasites were recorded, and the prevalence and
arithmetic mean intensity of infection (epg) including
both positive and negative individuals was calculated
[29]. To minimize the measurement bias on the parasito-
logical data, all Kato-Katz slides were read within 2 h of
preparation to avoid the degeneration of hookworm eggs,
and 10% of the total slides were randomly selected and
read by a second experienced microscopist for quality
control. Prior to each examination, written informed con-
sents were obtained from each participant for adults and
from head teachers for school children with verbal con-
sents from parents.
Data management and analysis
Each individual in the cohorts was given a specific, but
anonymous, identification number. Once collected, all
data were computerized into the database according to
the identification numbers. Of 4351 schoolchildren
recruited at baseline, 1704 were successfully examined at
baseline and re-examined at both follow-ups, and there-
fore, have the three complete sets of longitudinal parasi-
tological data. These longitudinal data, together with
three sets of cross-sectional data from the 6-year-old chil-
dren, were presented in the current descriptive analysis for
schoolchildren. The baseline characteristics of the chil-
dren successfully followed up were similar to those
dropped-out in mean age (8.0 vs 8.1), sex ratio (1.04 vs
1.02), hookworm prevalence (51% vs 52.2%), and hook-
worm intensity of infection (302.9 epg vs 283.8 epg) (p >
Table 1: S. mansoni prevalence and intensity of infection in the school children before and after treatment
Number of 
subjects
Baseline Follow-up Year 1 Follow-up Year 2 Overall reduction
Prevalence
Overall prevalence (%) 1 704 42.4 (40.0–44.7) 26.8 (24.7–28.9) 17.9 (16.1–19.7) 57.8%
Regions
Albertine Nile 638 33.4 (29.7–37.0) 18.0 (15.0–21.0) 9.7 (7.4–12.0) 71.0%
Lake Albert 335 49.3 (43.9–54.6) 39.1 (33.9–44.3) 29.6 (24.7–34.4) 40.0%
Lake Victoria 731 47.1 (43.4–50.7) 28.7 (25.4–32.0) 19.7 (16.8–22.6) 58.0%
Original category
High 620 77.2 (73.9–80.5) 56.9 (53.0–60.8) 38.5 (34.6–42.3) 50.1%
Medium 795 29.9 (26.7–33.1) 12.8 (10.5–15.1) 8.0 (6.2–9.9) 73.2%
Low 289 2.1 (0.4–3.7) 0.7 (0.0–1.7) 1.0 (0.0–2.2) 52.4%
Sex
Boys 879 41.5 (38.3–44.8) 27.1 (24.1–30.0) 18.3 (15.8–20.9) 55.9%
Girls 821 43.2 (39.9–46.6) 26.4 (23.4–29.5) 17.3 (14.7–19.9) 60.0%
Intensity of infection
Overall
Mean epg 1 704 219.6 (191.8–247.4) 73.4 (58.7–88.0) 37.4 (27.4–47.5) 83.0%
0 epg (%) - 57.6 (55.3–60.0) 73.2 (71.1–75.3) 82.1 (80.3–83.9) -
1–99 epg (%) - 16.2 (14.4–17.9) 14.6 (12.9–16.2) 11.5 (10.0–13.0) -
100–399 epg (%) - 11.1 (9.6–12.6) 7.3 (6.1–8.6) 4.1 (3.2–5.1) -
≥ 400 epg (%) - 15.1 (13.4–16.8) 4.9 (3.8–5.9) 2.3 (1.6–3.0) -
Region
Albertine Nile 638 105.7 (80.6–130.8) 44.2 (30.7–57.5) 11.6 (6.1–17.1) 89.0%
Lake Albert 335 386.8 (300.3–473.3) 165.9 (105.0–226.9) 84.1 (47.7–120.6) 78.3%
Lake Victoria 731 242.3 (197.2–287.4) 56.4 (41.0–71.8) 38.6 (23.2–54.0) 84.1%
Original category
High 620 522.3 (454.6–590.0) 175.8 (138.6–213.0) 86.6 (63.8–109.3) 83.4%
Medium 795 60.2 (45.5–74.8) 20.2 (10.5–29.8) 12.7 (1.2–24.2) 78.9%
Low 289 10.1 (0.0–12.7) 0.3 (0.0–1.0) 0.4 (0.0–1.0) 96.0%
Sex
Boys 879 233.1 (190.8–275.5) 77.8 (53.4–102.1) 32.8 (23.2–42.4) 85.9%
Girls 821 205.9 (170.2–241.6) 68.2 (52.4–84.0) 42.5 (24.4–60.6) 79.4%
Figures in () indicate 95% confidence interval.Page 4 of 11
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tion were higher in those dropped out (47.5% and 314.1
epg) than in those followed up (42.4% and 219.6 epg) (p
< 0.05). For adult data, as the majority of original adult
recruits could not be followed-up for the study period
(very few have the three complete sets of longitudinal
data), the cross-sectional data from all adults examined at
each visit were presented here. Frequency tables together
with 95% confidence intervals (CIs) were obtained using
software SAS v.8 (SAS Institute, Cary, NC, USA).
Results
Impact on the prevalence and intensity of intestinal 
schistosomiasis in schoolchildren
The results are summarized in Table 1. The overall preva-
lence was 42.4% at baseline. In different regions the Lake
regions had a higher prevalence than the Albertine Nile
region (Table 1). The average prevalence was 77.2% in
high category schools, 29.9% in medium category
schools, and 2.1% in low category schools. The prevalence
of schistosome infection was not significantly different
between boys and girls (Table 1). After PZQ treatment, the
overall prevalence was significantly reduced to 26.8%
after the first round of treatment and to 17.9% after the
second round of treatment, a total reduction of 57.8%. In
different regions, a greater reduction (71%) was shown in
the Nile region than in the Lake Victoria region (58.2%)
or in the Lake Albert region (40%). In different endemic
categories, the highest percentage reduction in prevalence
(73.2%) was shown in the medium category schools,
while the prevalence in high or low category schools was
reduced by half. A similar degree of reduction in schisto-
some prevalence was observed in both genders after treat-
ments, as shown in Table 1.
At baseline, 15% of the children had heavy S. mansoni
infections (≥ 400 epg), and the arithmetic mean intensity
of infection of all participants was 219.6 epg (Table 1).
There was no significant difference in the mean intensities
between the boys and the girls. In different regions, the
highest mean intensity of schistosome infection (386.8
epg) was found in the Lake Albert region while the lowest
mean intensity (105.7 epg) was recorded in the Albertine
Nile region. In schools of different endemic categories, the
heaviest infection was in schools of high endemic cate-
gory with an arithmetic mean intensity of 522.3 epg. After
two rounds of PZQ treatment, the proportion of the heavy
infections with S. mansoni was reduced to only 2.3% at the
second follow-up (Table 1). The overall arithmetic mean
intensity of infection was reduced by 83%. Similar reduc-
tion was observed in both boys and girls after treatment,
with a total reduction of 85.9% and 79.4% respectively at
the second follow-up. Although the percentage reduction
in mean intensity looks higher in the Albertine Nile
region, the absolute reduction inepg in both lake regions
was much steeper: 300 epg (Lake Albert) and 200 epg
(Lake Victoria), respectively. Similarly in different
endemic categories, the most noticeable reduction inepg
was in schools of high category, by over 400 epg.
Impact on the prevalence and intensity of intestinal 
schistosomiasis in community adults
The results for adults are from the cross-sectional data
(Table 2). Overall prevalence of S. mansoni infection was
57.4% at baseline, higher in males than in females. As in
children, the prevalence of S. mansoni infection in adults
in the Lake regions was higher than in the Albertine Nile
region (Table 2). Two rounds of treatment achieved a total
reduction of 82.9% in the overall prevalence. There was
no difference in prevalence between males and females
after two rounds of treatment. The prevalence in both gen-
ders was significantly reduced from baseline by 85.6% in
males and 79.5% in females. As in Table 2, the percentage
reduction in three regions was 72.9% in the Lake Albert
region, 82.5% in the Lake Victoria region, and 85.8% in
the Albertine Nile region.
In these adults, 16.8% of population had heavy S. mansoni
infections, and the arithmetic mean intensity of infection
was 251.6 epg at baseline. Males were significantly more
heavily infected than females. Generally speaking, those
in the Lake Albert region were most heavily infected, and
those in the Albertine Nile region were least heavily
infected. As shown in Table 2, after two rounds of treat-
ment the arithmetic mean intensity of S. mansoni infec-
tion was dramatically reduced to 19.6 epg, a reduction of
92.2%. The proportion of heavy infections decreased to
only 1%. There was no difference in intensity of infection
between males and females after two rounds of treatment,
with a greater degree of reduction shown in males.
Impact on the prevalence and intensity of STH in 
schoolchildren
The overall prevalence of hookworm infection was 50.9%
at baseline. It was slightly higher in the Lake Victoria
region than in the Albertine Nile region or in the Lake
Albert region, respectively (Table 3). There was no signifi-
cant difference in prevalence of hookworm infection
between boys and girls at baseline. After ALB treatment,
the overall prevalence was reduced to 24.1% after the first
treatment and to 10.7% after the second treatment,
respectively, representing a reduction of 79%. Substantive
decreases in prevalence were seen in all three regions, and
even after one treatment the hookworm infection in the
Lake Albert and the Nile regions was reduced by over
75%. Both boys and girls showed similar improvement in
reducing prevalence of hookworm infections.
Most of the hookworm infections were light infections at
baseline (<2000 epg) as in Table 3 with an estimatedPage 5 of 11
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was no significant difference in mean intensity between
genders, and the highest mean intensity was found
around Lake Victoria (Table 3). After two rounds of treat-
ment with ALB, the arithmetic mean intensity of infection
significantly decreased to 21.9 epg. The percentage reduc-
tion in the mean intensity was similar between the gen-
ders and in the different regions; however, the absolute
reduction in the mean intensity was much greater in the
Lake Albert and Lake Victoria regions, where the initial
mean intensity was higher.
The prevalence of A. lumbricoides or T. trichiura was rela-
tively low in the cohort areas (Table 3). The prevalence of
A. lumbricoides was reduced from 2.8% to 0.6%, and the
intensity of infection was reduced by 83%, however the
impact was negligible because of the very light infections
in these areas. The prevalence of T. trichiura did not show
much change, maintaining at around a 2% level, and
there was no significant change in the mean intensity of T.
trichiura infections either. Analysis of A. lumbricoides or T.
trichiura infection by different epidemiological settings
did not show any statistical differences, therefore, such
details are not presented in this paper.
Impact on the prevalence and intensity of STH in 
community adults
At baseline, hookworm prevalence was 31.7%, and there
was no significant difference between males and females,
as shown in Table 4. In contrast to schistosome infection,
the prevalence of hookworm infection was significantly
lower in the Lake Albert region than in the Lake Victoria
region and in the Albertine Nile region. After two rounds
of treatment, the prevalence decreased by 61.8% in total,
68.2% in males, and 56.1% in females. Significant reduc-
tion was shown in all three regions (Table 4).
Hookworm infections in adults were mainly light infec-
tions (Table 4). Arithmetic mean intensity of infection
was 121.9 epg at baseline, and relatively heaviest infec-
tions were seen in the Lake Victoria region among three
different regions. After two rounds of treatment, the inten-
sity of infection decreased by a near 72% reduction in
total. A significant reduction was observed in all three
regions (Table 4). A. lumbricoides and T. trichiura infec-
tions were observed at a very low level (around 1%), and
no significant impact was seen on these by the treatment.
Table 2: S. mansoni prevalence and intensity of infection in the community adults before and after treatment (cross-sectional data)
Baseline Follow-up Year 1 Follow-up Year 2 Overa
ll 
reduc
tion
Prevalence
Overall prevalence (%) 57.4 (54.1–60.6) (n = 903) 34.7 (31.1–38.2) (n = 689) 9.8 (6.9–12.8) (n = 397) 82.9%
Regions
Albertine Nile 43.1 (35.9–50.3) (n = 181) 16.1 (10.2–22.0) (n = 149) 6.1 (1.7–10.6) (n = 114) 85.8%
Lake Albert 65.6 (60.2–70.9) (n = 302) 42.9 (35.2–50.7) (n = 156) 17.8 (6.6–28.9) (n = 45) 72.9%
Lake Victoria 57.6 (52.9–62.4) (n = 420) 38.5 (33.7–43.4) (n = 384) 10.1 (6.3–13.9) (n = 238) 82.5%
Sex
Male 64.6 (60.2–69.1) (n = 441) 40.1 (34.5–45.7) (n = 294) 9.3 (5.3–13.2) (n = 205) 85.6%
Female 48.2 (43.4–53.0) (n = 413) 28.5 (23.3–33.7) (n = 288) 9.9 (5.7–14.2) (n = 191) 79.5%
Intensity of infection
Overall
Mean epg 251.6 (213.7–289.6) (n = 903) 80.4 (61.1–99.7) (n = 689) 19.6 (4.9–34.3) (n = 397) 92.2%
0 epg (%) 42.6 (39.4–45.9) (n = 385) 65.3 (61.7–68.9) (n = 450) 90.2 (87.3–93.1) (n = 358) -
1–99 epg (%) 23.7 (20.9–26.5) (n = 214) 19.3 (16.4–22.3) (n = 133) 6.8 (4.3–9.3) (n = 27) -
100–399 epg (%) 16.8 (14.4–19.3) (n = 152) 10.2 (7.9–12.4) (n = 70) 2.0 (0.6–3.4) (n = 8) -
≥ 400 epg (%) 16.8 (14.4–19.3) (n = 152) 5.2 (3.6–6.9) (n = 36) 1.0 (0.0–2.0) (n = 4) -
Region
Albertine Nile 67.6 (46.3–89.0) (n = 181) 31.0 (9.4–52.5) (n = 149) 2.5 (0.1–4.8) (n = 116) 96.3%
Lake Albert 411.2 (321.6–500.7) (n = 302) 131.9 (74.9–189.0) (n = 156) 62.0 (0.0–167.6) (n = 48) 84.9%
Lake Victoria 216.2 (169.7–262.6) (n = 420) 78.7 (54.5–102.9) (n = 384) 18.4 (5.9–30.8) (n = 247) 91.5%
Sex
Male 346.9 (285.0–408.8) (n = 441) 101.8 (65.8–137.9) (n = 294) 19.6 (0.0–44.4) (n = 205) 94.3%
Female 154.9 (107.6–202.2) (n = 413) 69.2 (42.9–95.6) (n = 288) 19.7 (4.6–34.9) (n = 191) 87.3%
Figures in () indicate 95% confidence interval; n, number of subjects in the group.Page 6 of 11
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of infection in new 6-year-old untreated cohorts
Cohorts of the 6-year-olds from each school were
recruited at baseline and at each of both follow-ups. These
new cohort children were the first year pupils who had not
had the history of previous treatment before they joined
the school. Any children indicating, during the question-
naire survey, that they might have received treatment were
excluded from analysis here. The data from these children
should provide an indicator for the transmission levels in
the areas. As shown in Table 5, at baseline, 34.9% of the
6-year-old children were infected with S. mansoni, and
48.4% infected with hookworms. After two rounds of
treatment the prevalence and intensity of both S. mansoni
and hookworm infections in the untreated 6-year olds sig-
nificantly decreased (Table 5). A greater reduction was
shown in hookworm infections. Even after one treatment
a significant decrease was seen in both hookworm preva-
lence and intensity of infection. Such reduction was
prominent in all three different regions, with the highest
reduction in both S. mansoni and hookworm infections in
the Albertine Nile region (Table 5).
Discussion
Baseline data from 37 primary schools and nine commu-
nities in eight districts illustrated the significant burden of
schistosomiasis and STH in Uganda. Prevalence of S. man-
soni infection was nearly 100% in many schools, and 15%
of children were heavily infected (≥ 400 epg). Hookworm
infection was widespread in all areas, with an average
prevalence of 50% in children. It was evident that the bur-
den of these parasitic infections had not changed in the
country until the current Schistosomiasis Control Initia-
tive – supported national control program initiated in
2003 [16,18,21,30,31]. The main control strategies of the
current program include chemotherapy and health educa-
Table 3: Soil-transmitted helminth prevalence and intensity of infection in the school children before and after treatment
No of subjects Baseline Follow-up Year 1 Follow-up Year 2 Overall reduction
Hookworm
Prevalence (%)
Overall 1 704 50.9 (48.6–53.3) 24.1 (22.1–26.2) 10.7 (9.3–12.2) 79.0%
Regions
Albertine Nile 637 48.0 (44.2–51.9) 11.6 (9.1–14.1) 5.5 (3.7–7.3) 88.5%
Lake Albert 335 41.2 (35.9–46.5) 8.4 (5.4–11.3) 9.0 (5.9–12.0) 78.2%
Lake Victoria 732 57.9 (54.3–61.5) 42.2 (38.6–45.8) 16.1 (13.5–18.8) 72.2%
Sex
Boys 877 53.5 (50.2–56.8) 27.3 (24.3–30.2) 12.2 (10.0–14.4) 77.2%
Girls 823 48.2 (44.8–51.7) 20.8 (18.0–23.6) 9.2 (7.3–11.2) 80.9%
Intensity of 
infection (epg)
Overall
Mean epg 1 704 309.4 (232.4–386.4) 76.8 (62.9–90.7) 21.9 (13.8–30.1) 92.9%
0 epg (%) - 49.0 (46.7–51.4) 75.9 (73.8–77.9) 89.3 (87.8–90.7) -
1–1 999 epg (%) - 48.4 (46.0–50.7) 23.5 (21.5–25.5) 10.6 (9.2–12.1) -
2 000–3 999 epg 
(%)
- 1.6 (1.0–2.2) 0.5 (0.1–0.8) 0.1 (0.0–0.2) -
≥ 4 000 epg (%) - 1.0 (0.5–1.5) 0.1 (0.0–0.3) 0.1 (0.0–0.2) -
Region
Albertine Nile 637 186.9 (148.0–225.8) 29.6 (17.1–42.2) 3.7 (1.7–5.7) 98.0%
Lake Albert 335 307.4 (1.2–613.6) 22.8 (9.3–36.2) 23.9 (0.0–51.4) 92.2%
Lake Victoria 732 416.8 (310.0–523.5) 142.6 (113.4–171.8) 36.9 (22.8–50.9) 91.1%
Sex
Boys 877 370.3 (229.5–511.1) 76.7 (60.5–92.8) 19.4 (12.3–26.5) 94.8%
Girls 823 244.5 (190.7–298.4) 77.3 (54.3–100.4) 24.7 (9.6–39.8) 89.9%
Ascaris lumbricoides
Overall prevalence 
(%)
1 700 2.8 (2.0–3.6) 1.6 (1.0–2.3) 0.6 (0.3–1.0) -
Intensity of infection 
(epg)
1 700 95.4 (26.4–164.3) 20.0 (4.9–35.1) 16.2 (3.5–28.9) 83.0%
Trichuris trichiura
Overall prevalence 
(%)
1 700 2.2 (1.5–2.9) 2.5 (1.7–3.2) 1.6 (1.0–2.2) -
Intensity of infection 
(epg)
1 700 3.3 (0.9–5.6) 1.8 (1.0–2.7) 3.05 (0.0–7.15) -
Figures in () indicate 95% confidence interval.Page 7 of 11
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the World Health Assembly resolution 54.19, at least 75%
of all school-aged children at risk of morbidity due to
schistosomiasis and STH should be given regular treat-
ment by 2010. The treatment coverage of school-aged
children in our program has been shown to be well above
the 75% threshold [26]. Our data suggest that this has
resulted in a remarkable reduction of the burden due to
these parasitic infections [24,25,27]. After two rounds of
treatment with PZQ and ALB, significant reduction was
observed in both prevalence and, more importantly,
intensity of infection of S. mansoni and hookworms.
Two rounds of treatment in adults also showed a tremen-
dous impact on the prevalence and intensity of S. mansoni
and hookworm infections. However, it was noticed that
the prevalence and intensity of hookworm infections were
not reduced after the first round of treatment. This might
have been due to the high dropout rate of adults from
baseline and the recruitment of additional (different)
individuals at follow-ups. It should also be noted that our
adult data were obtained from the communities where the
original S. mansoni prevalence in schoolchildren was high
(>50%). Therefore, the adult data represent the situation
only in such areas.
To evaluate the potential longer-term impact of the pro-
gram, we examined the infections in the 6-year-old chil-
dren who had not received treatment previously as they
had only recently started attending school. It might be an
important observation that both S. mansoni and hook-
worm infections in this group of children significantly
decreased after two rounds of treatment (Table 5), sug-
gesting that the level of environmental transmission in
these areas could have been reduced because of overall
reductions in excreted eggs from infected children, or
owing to altered contaminating behaviours of the chil-
dren as health education activities concurrent with
administration of anthelmintics took place. The highest
reduction in both S. mansoni and hookworm infections in
Table 4: Soil-transmitted helminth prevalence and intensity of infection in the community adults before and after treatment
Baseline Follow-up Year 1 Follow-up Year 2 Overall reduction
Hookworm
Prevalence (%)
Overall 31.7 (28.6–34.7) (n = 903) 36.1 (32.6–39.7) (n = 689) 12.1 (8.9–15.3) (n = 397) 61.8%
Regions
Albertine Nile 34.3 (27.3–41.2) (n = 181) 28.2 (21.0–35.4) (n = 149) 7.0 (2.3–11.7) (n = 114) 79.6%
Lake Albert 14.2 (10.3–18.2) (n = 302) 12.2 (7.1–17.3) (n = 156) 0.0 (NA) (n = 45) 100%
Lake Victoria 43.1 (38.4–47.8) (n = 420) 49.0 (44.0–54.0) (n = 384) 16.8 (12.1–21.6) (n = 238) 61.0%
Sex
Male 27.7 (23.5–31.8) (n = 441) 30.3 (25.0–35.5) (n = 294) 8.8 (4.9–12.7) (n = 205) 68.2%
Female 35.8 (31.2–40.5) (n = 413) 36.1 (30.6–41.7) (n = 288) 15.7 (10.6–20.9) (n = 191) 56.1%
Intensity of infection
Overall
Mean epg 121.9 (92.6–151.1) (n = 
903)
142.6 (101.5–183.7) (n = 
689)
34.3 (15.5–53.1) (n = 397) 71.9%
0 epg (%) 68.3 (65.3–71.4) (n = 617) 63.9 (60.3–67.4) (n = 440) 87.9 (84.7–91.1) (n = 349) -
1–1 999 epg (%) 30.7 (27.7–33.7) (n = 277) 35.0 (31.4–38.5) (n = 241) 11.8 (8.7–15.0) (n = 47) -
2 000–3 999 epg (%) 0.7 (0.1–1.2) (n = 6) 0.4 (0.0–0.9) (n = 3) 0.3 (NA) (n = 1) -
≥ 4 000 epg (%) 0.3 (0.0–0.7) (n = 3) 0.7 (0.1–1.4) (n = 5) 0.00 (NA) (n = 0) -
Regions
Albertine Nile 79.3 (49.4–109.2) (n = 181) 54.9 (18.1–91.7) (n = 149) 10.1 (0.0–20.5) (n = 114) 87.3%
Lake Albert 47.3 (10.8–83.7) (n = 302) 38.2 (10.8–65.6) (n = 156) 0.00 (NA) (n = 45) 100%
Lake Victoria 193.8 (138.7–248.9) (n = 
420)
219.0 (148.3–289.7) (n = 
384)
52.3 (21.5–83.1) (n = 238) 73.0%
Sex
Male 99.4 (63.2–135.6) (n = 441) 137.6 (59.8–215.3) (n = 
294)
18.6 (4.8–32.5) (n = 205) 81.3%
Female 154.1 (103.3–205.0) (n = 
413)
124.1 (88.9–159.2) (n = 
288)
51.3 (15.1–87.4) (n = 191) 66.7%
Ascaris lumbricoides
Overall prevalence (%) 1.0 (0.4–1.7) (n = 903) 1.5 (0.6–2.3) (n = 689) 0.5 (0.0–1.2) (n = 397) -
Mean epg 2.4 (0.0–5.6) (n = 903) 6.3 (0.6–11.9) (n = 689) 3.6 (0.0–10.5) (n = 397) -
Trichuris trichiura
Overall prevalence (%) 1.3 (0.6–2.1) (n = 903) 1.2 (0.4–2.0) (n = 689) 0.8 (0.0–1.6) (n = 397) -
Mean epg 0.6 (0.2–1.1) (n = 903) 1.6 (0.0–3.4) (n = 689) 0.7 (0.0–1.7) (n = 397) -
Figures in () indicate 95% confidence interval; n, number of subjects in the group; NA, not available.Page 8 of 11
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mission of the diseases in the region. For schistosomiasis
a simple explanation is available: the Albertine Nile offers
less convenient platforms for human water contact than
the shorelines of the lakes owing to the increased riverine
current and dangerously steep shelving banks.
The ultimate goal of the current control strategy recom-
mended by the World Health Organization is to reduce
the morbidity due to schistosomiasis and STH. The conse-
quence of these parasitic infections has been well studied
and documented. Apart from the liver and spleen pathol-
ogy caused by intestinal schistosomiasis, anaemia, growth
stunting, and cognitive impairment are also linked to
these infections [14,32,33]. Our data also showed a strong
link between anaemia and both S. mansoni and hook-
worm infections [24]. By studying two neighbouring com-
munities in Uganda, Booth and colleagues showed that
the development of hepatosplenic morbidity due to S.
mansoni can be critically related to the duration of expo-
sure to S. mansoni infections [34]. Therefore, repeated
treatment as early in childhood as possible is particularly
important to avoid the devastating consequences at a later
stage of life [35]. And, indeed, one round of treatment has
already shown a sign of improvement in children's health
[24]. Distended abdomen syndrome in schoolchildren, as
defined by an abdominal circumference ratio, was shown
to likely improve after the first round of treatment [27].
With the program progressing, and more treatment and
health education being delivered, long-lasting health ben-
efits will undoubtedly be brought to Ugandan children.
In line with the previous data [21], infections with A. lum-
bricoides and T. trichiura in the current study areas are rel-
Table 5: Prevalence and intensity of S. mansoni and hookworm infections in the newly-recruited cohorts of previously untreated 6-year-
old children before and after treatment
Baseline Follow-up Year 1 Follow-up Year 2 Overall reduction
S. mansoni
Prevalence (%)
Overall 34.9 (31.9–37.8) (n = 1 
018)
27.7 (25.0–30.4) (n = 1 
075)
22.6 (19.9–25.2) (n = 961) 35.2%
Region
Albertine Nile 22.4 (17.9–26.9) (n = 330) 12.9 (9.5–16.4) (n = 371) 11.3 (7.9–14.6) (n = 346) 49.6%
Lake Albert 47.5 (41.3–53.6) (n = 255) 42.4 (36.7–48.1) (n = 288) 32.3 (26.3–38.4) (n = 229) 32.0%
Lake Victoria 37.0 (32.4–41.5) (n = 433) 30.8 (26.3–35.2) (n = 416) 26.9 (22.5–31.4) (n = 386) 27.3%
Intensity of infection 
(epg)
Overall 171.1 (141.5–200.7) (n = 1 
018)
119.9 (92.1–147.8) (n = 1 
075)
72.0 (50.9–93.1) (n = 961) 57.9%
Region
Albertine Nile 93.7 (53.4–133.9) (n = 330) 42.7 (18.9–66.5) (n = 371) 10.8 (6.1–15.4) (n = 346) 88.5%
Lake Albert 152.9 (111.9–193.8) (n = 
433)
84.2 (55.9–112.5) (n = 416) 86.2 (59.2–113.3) (n = 386) 43.6%
Lake Victoria 302.3 (223.9–380.7) (n = 
255)
271.1 (182.7–359.5) (n = 
288)
140.6 (65.6–215.6) (n = 
229)
53.5%
Hookworms
Prevalence (%)
Overall 48.4 (45.4–51.5) (n = 1 
018)
24.7 (22.1–27.3) (n = 1 
075)
15.9 (13.6–18.2) (n = 961) 67.1%
Region
Albertine Nile 46.1 (40.7–51.4) (n = 330) 14.0 (10.5–17.6) (n = 371) 10.7 (7.4–14.0) (n = 346) 76.8%
Lake Albert 39.6 (33.6–45.6) (n = 255) 10.8 (7.2–14.4) (n = 287) 12.2 (8.0–16.5) (n = 229) 69.2%
Lake Victoria 55.4 (50.8–60.2) (n = 433) 43.6 (38.9–48.4) (n = 417) 22.8 (18.6–27.0) (n = 386) 58.8%
Intensity of infection 
(epg)
Overall 232.7 (188.4–276.9) (n = 1 
018)
84.6 (63.6–105.6) (n = 1 
075)
51.4 (33.4–69.5) (n = 961) 77.9%
Region
Albertine Nile 184.1 (137.2–231.0) (n = 
330)
39.7 (6.7–72.7) (n = 371) 27.8 (8.4–47.3) (n = 346) 84.9%
Lake Albert 171.0 (97.4–244.7) (n = 
255)
20.2 (9.6–30.8) (n = 288) 32.2 (4.5–59.8) (n = 229) 81.2%
Lake Victoria 306.0 (218.6–393.4) (n = 
433)
168.9 (124.9–212.8) (n = 
416)
84.0 (46.0–122.0) (n = 386) 72.5%
Figures in () indicate 95% confidence intervals; n, number of subjects in the group.Page 9 of 11
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in certain parts of the country and do not constitute a
major health problem in our study areas. It is noticed
from the present data that ALB efficacy at the current dose
level (400 mg per person) was high on hookworms and
on A. lumbricoides in children, as the prevalence and inten-
sity of both infections decreased significantly after treat-
ment. However, in agreement with previous reports by
others [36-38], this dose was ineffective for the treatment
of T. trichiura. As the program progresses and treatment is
extended to southwestern Uganda, where T. trichiura
infection rates could be as high as 100% (NK, unpub-
lished data), a different treatment regimen, e.g., multiple
treatment with ALB, should be considered to achieve bet-
ter cure rates on T. trichiura [5,39].
Despite the progress made, it was generally observed that
in cohort schools close to lakeshores, the prevalence and
intensity of S. mansoni infection remained relatively high
even after two rounds of treatment (data not shown). This
could imply that transmission at these locations is persist-
ently at a high level, and special attention should be
devoted to such locations to bring about a further decline
in transmission. However, a high treatment coverage rate
is instrumental in controlling schistosomiasis transmis-
sion [40]. Although a minimum 80% coverage in the
schools has been achieved at any time point in this pro-
gram, frequent migration of people particularly from the
fishing communities, some of whom are from neighbour-
ing countries, and absence from school of some school-
aged children remain significant hurdles to the successful
implementation of the control program, particularly in
terms of ensuring repeated treatment. A concerted action
of all neighbouring countries to offer treatment in the
neighbouring states would significantly improve the situ-
ation. The current implementation of the control program
is being integrated with the national child health days in
Uganda, and this might also help to improve the treat-
ment coverage in school-aged children. An epidemiologi-
cal remapping of the current endemic status of these
parasitic infections amid the ongoing control program is
now being carried out. The results will enable Uganda to
identify those problem areas where transmission is per-
sistently high so as to adjust the treatment strategy in each
community to further bring down the level of infections,
hence morbidity. Efforts are also being made to find addi-
tional funds to sustain the impact achieved in the long
term.
Conclusion
The current study has clearly demonstrated the significant
impact of a national control program in sub-Saharan
Africa at reducing the prevalence and intensity of schisto-
somiasis and STH and even potential environmental
transmission of these diseases. We therefore set an exam-
ple of successful implementation of a national control
program to combat these important neglected tropical
diseases in underdeveloped countries.
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